Bulk Manufacturer of Controlled Substances Application: PCAS-NANOSYN, LLC, 24452 [2014-09576]
Download as PDF
<![CDATA[
24452
Federal Register / Vol. 79, No. 83 / Wednesday, April 30, 2014 / Notices
6(a) of the Act. The Department of
Justice published a notice in the Federal
Register pursuant to Section 6(b) of the
Act on June 29, 2000 (65 FR 40127).
The last notification was filed with
the Department on December 20, 2013.
A notice was published in the Federal
Register pursuant to Section 6(b) of the
Act on January 28, 2014 (79 FR 4492).
To submit
comments:
Send them to:
By email .........
pubcomment-ees.enrd@
usdoj.gov.
Acting Assistant Attorney
General, U.S. DOJ—
ENRD, P.O. Box 7611,
Washington, DC 20044–
7611.
Patricia A. Brink,
Director of Civil Enforcement, Antitrust
Division.
During the public comment period,
the consent decree may be examined
and downloaded at this Department of
Justice Web site: https://www.usdoj.gov/
enrd/Consent_Decrees.html. We will
provide a paper copy of the consent
decree upon written request and
payment of reproduction costs. Please
mail your request and payment to:
Consent Decree Library, U.S. DOJ—
ENRD, P.O. Box 7611, Washington, DC
20044–7611. Please enclose a check in
the amount of $19.25 (25 cents per page
reproduction cost) payable to the United
States Treasury.
[FR Doc. 2014–09787 Filed 4–29–14; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
mstockstill on DSK4VPTVN1PROD with NOTICES
Notice of Lodging of Proposed
Consent Decree Under the Clean Air
Act
On April 24, 2014, the Department of
Justice lodged a proposed consent
decree with the United States District
Court for the Northern District of Ohio
in the lawsuit entitled United States v.
City of Akron, et al., Civil Action No.
5:14-cv-00884.
In the Complaint, the United States
alleges that the City of Akron (‘‘City’’)
and Akron Energy Systems LLC (‘‘AES’’)
(collectively ‘‘Defendants’’) violated, at
a steam generating facility that they own
and operate, respectively, in Akron,
Ohio, the Prevention of Significant
Deterioration regulations and the New
Source Performance Standards, both
promulgated under the Clean Air Act,
42 U.S.C. 7401 et seq.
Under the consent decree, the
Defendants will shut down the facility’s
coal-fired boiler by no later than
September 30, 2015. The City will either
replace the steam-generating capacity of
the coal-fired boiler with one or more
cleaner-burning natural gas-fired boilers
or elect to shut down the facility. The
City will pay a civil penalty of $75,000
and undertake a project costing no less
than $390,000 to mitigate the harm of
the alleged prior excess emissions from
the coal-fired boiler.
The publication of this notice opens
a period of public comment on the
consent decree. Comments should be
addressed to the Acting Assistant
Attorney General, Environment and
Natural Resources Division, and should
refer to United States v. City of Akron,
et al., D.J. Ref. No. 90–5–2–1–08720/1.
All comments must be submitted no
later than thirty (30) days after the
publication date of this notice.
Comments may be submitted either by
email or by mail:
VerDate Mar<15>2010
17:41 Apr 29, 2014
Jkt 232001
By mail ...........
Maureen M. Katz,
Assistant Section Chief, Environmental
Enforcement Section, Environment and
Natural Resources Division.
[FR Doc. 2014–09801 Filed 4–29–14; 8:45 am]
BILLING CODE 4410–15–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: PCAS–
NANOSYN, LLC
Notice of application with
opportunity for comment.
ACTION:
Registered bulk manufacturers of
the affected basic classes and applicants
therefore may file written comments or
objections to the issuance of the
proposed registration in accordance
with 21 CFR 1301.33(a) on or before
June 30, 2014.
ADDRESSES: Written comments should
be sent via regular or express mail to:
Drug Enforcement Administration,
Attention: DEA Federal Register
Representative/ODW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
DATES:
PO 00000
Frm 00082
Fmt 4703
Sfmt 4703
manufacturers, distributors, and
dispensers of controlled substances
(other than final orders in connection
with suspension, denial, or revocation
of registration) has been re-delegated to
the Deputy Assistant Administrator of
the DEA Office of Diversion Control
(‘‘Deputy Assistant Administrator’’)
pursuant to sec. 7(g) of 28 CFR pt. 0,
subpt. R, App.
In accordance with 21 CFR
1301.33(a), this is notice that on
December 4, 2013, PCAS-Nanosyn, LLC,
3331–B Industrial Drive, Santa Rosa,
California 95403, made application by
renewal to the DEA to be registered as
a bulk manufacturer of the following
basic classes of narcotic and
nonnarcotic controlled substances:
Controlled
substance
Schedule
Narcotic/
Nonnarcotic
Amphetamine
(1100).
Methamphetamine (1105).
Methylphenidate
(1724).
Phencyclidine
(7471).
Codeine (9050) ...
Oxycodone
(9143).
Hydromorphone
(9150).
Hydrocodone
(9193).
Methadone (9250)
Morphine (9300)
Oripavine (9330)
Oxymorphone
(9652).
Fentanyl (9801) ...
II .............
nonnarcotic.
II .............
nonnarcotic.
II .............
nonnarcotic.
II .............
nonnarcotic.
II .............
II .............
narcotic.
narcotic.
II .............
narcotic.
II .............
narcotic.
II
II
II
II
.............
.............
.............
.............
narcotic.
narcotic.
narcotic.
narcotic.
II .............
narcotic.
The company is a contract
manufacturer. At the request of the
company’s customers, it manufactures
derivatives of controlled substances
only in bulk form.
Dated: April 21, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014–09576 Filed 4–29–14; 8:45 am]
BILLING CODE 4410–09–P
FOREIGN CLAIMS SETTLEMENT
COMMISSION
[F.C.S.C. Meeting and Hearing Notice No.
05–14]
Sunshine Act Meeting
The Foreign Claims Settlement
Commission, pursuant to its regulations
(45 CFR part 503.25) and the
Government in the Sunshine Act (5
U.S.C. 552b), hereby gives notice in
regard to the scheduling of open
meetings as follows:
E:\FR\FM\30APN1.SGM
30APN1
]]>Agencies
[Federal Register Volume 79, Number 83 (Wednesday, April 30, 2014)]
[Notices]
[Page 24452]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-09576]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: PCAS-
NANOSYN, LLC
ACTION: Notice of application with opportunity for comment.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes and
applicants therefore may file written comments or objections to the
issuance of the proposed registration in accordance with 21 CFR
1301.33(a) on or before June 30, 2014.
ADDRESSES: Written comments should be sent via regular or express mail
to: Drug Enforcement Administration, Attention: DEA Federal Register
Representative/ODW, 8701 Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, and dispensers of controlled substances
(other than final orders in connection with suspension, denial, or
revocation of registration) has been re-delegated to the Deputy
Assistant Administrator of the DEA Office of Diversion Control
(``Deputy Assistant Administrator'') pursuant to sec. 7(g) of 28 CFR
pt. 0, subpt. R, App.
In accordance with 21 CFR 1301.33(a), this is notice that on
December 4, 2013, PCAS-Nanosyn, LLC, 3331-B Industrial Drive, Santa
Rosa, California 95403, made application by renewal to the DEA to be
registered as a bulk manufacturer of the following basic classes of
narcotic and nonnarcotic controlled substances:
------------------------------------------------------------------------
Narcotic/
Controlled substance Schedule Nonnarcotic
------------------------------------------------------------------------
Amphetamine (1100).............. II.............. nonnarcotic.
Methamphetamine (1105).......... II.............. nonnarcotic.
Methylphenidate (1724).......... II.............. nonnarcotic.
Phencyclidine (7471)............ II.............. nonnarcotic.
Codeine (9050).................. II.............. narcotic.
Oxycodone (9143)................ II.............. narcotic.
Hydromorphone (9150)............ II.............. narcotic.
Hydrocodone (9193).............. II.............. narcotic.
Methadone (9250)................ II.............. narcotic.
Morphine (9300)................. II.............. narcotic.
Oripavine (9330)................ II.............. narcotic.
Oxymorphone (9652).............. II.............. narcotic.
Fentanyl (9801)................. II.............. narcotic.
------------------------------------------------------------------------
The company is a contract manufacturer. At the request of the
company's customers, it manufactures derivatives of controlled
substances only in bulk form.
Dated: April 21, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014-09576 Filed 4-29-14; 8:45 am]
BILLING CODE 4410-09-P
